Cargando…
Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864719/ https://www.ncbi.nlm.nih.gov/pubmed/35228872 http://dx.doi.org/10.1002/cti2.1378 |
| _version_ | 1784655514921074688 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8864719 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88647192022-02-27 Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity Clin Transl Immunology Retraction John Wiley and Sons Inc. 2022-02-23 /pmc/articles/PMC8864719/ /pubmed/35228872 http://dx.doi.org/10.1002/cti2.1378 Text en © 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity |
| title | Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity |
| title_full | Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity |
| title_fullStr | Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity |
| title_full_unstemmed | Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity |
| title_short | Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity |
| title_sort | retraction statement: dual targeting of rankl and pd‐1 with a bispecific antibody improves anti‐tumor immunity |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864719/ https://www.ncbi.nlm.nih.gov/pubmed/35228872 http://dx.doi.org/10.1002/cti2.1378 |